PRK2/PKN2 Polyclonal Antibody

Elabscience
Product Code: E-AB-92026
Product Group: Primary Antibodies
Supplier: Elabscience
CodeSizePrice
E-AB-92026-60uL60uL£210.00
Quantity:
E-AB-92026-120uL120uL£291.00
Quantity:
E-AB-92026-200uL200uL£431.00
Quantity:
Prices exclude any Taxes / VAT

Overview

Host Type: Rabbit
Antibody Isotype: IgG
Antibody Clonality: Polyclonal
Regulatory Status: RUO
Target Species:
  • Mouse
  • Rat
Application: Western Blot (WB)
Shipping:
Ice packs
Storage:
Store at -20°C. Avoid freeze/thaw cycles.

Images

1 / 1
Western blot analysis of extracts of Rat lung using PRK2/PRK2/PKN2 Polyclonal Antibody at 1:1000 dilution.

Western blot analysis of extracts of Rat lung using PRK2/PRK2/PKN2 Polyclonal Antibody at 1:1000 dilution.

Documents

Further Information

Abbreviation:
PRK2/PKN2
Background:
PKC-related serine/threonine-protein kinase and Rho/Rac effector protein that participates in specific signal transduction responses in the cell. Plays a role in the regulation of cell cycle progression, actin cytoskeleton assembly, cell migration, cell adhesion, tumor cell invasion and transcription activation signaling processes. Phosphorylates CTTN in hyaluronan-induced astrocytes and hence decreases CTTN ability to associate with filamentous actin. Phosphorylates HDAC5, therefore lead to impair HDAC5 import. Direct RhoA target required for the regulation of the maturation of primordial junctions into apical junction formation in bronchial epithelial cells. Required for G2/M phases of the cell cycle progression and abscission during cytokinesis in a ECT2-dependent manner. Stimulates FYN kinase activity that is required for establishment of skin cell-cell adhesion during keratinocytes differentiation. Regulates epithelial bladder cells speed and direction of movement during cell migration and tumor cell invasion. Inhibits Akt pro-survival-induced kinase activity. Mediates Rho protein-induced transcriptional activation via the c-fos serum response factor (SRF. Involved in the negative regulation of ciliogenesis.
Buffer:
PBS with 0.01% thiomersal,50% glycerol,pH7.3.
Calculated MW:
75kDa/94kDa/106kDa/110kDa/112kDa
Concentration:
1mg/mL
Conjugation:
Unconjugated
Dilution:
WB 1:500-1:2000
Immunogen:
A synthetic peptide of human PRK2/PRK2/PKN2
ObservedMW:
140kDa
Purification method:
Affinity purification
Target Synonym:
PAK2;PRK2;PRKCL2;PRO2042;Pak-2;STK7;PKN2
UNIProt ID:
Q16513